Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Heghine Khachatryan: From Imperial Tragedy to Modern Hemostasis – Lessons from the Romanov Case
Heghine Khachatryan/LinkedIn
Apr 17, 2026, 14:44

Heghine Khachatryan: From Imperial Tragedy to Modern Hemostasis – Lessons from the Romanov Case

Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:

“From Imperial Tragedy to Modern Hemostasis: Lessons from the Romanov Case

The case of Tsarevich Alexei Romanov remains one of the most widely cited historical narratives in the context of inherited bleeding disorders. As the only son of Tsar Nicholas II, Alexei suffered from severe hemophilia A – an X-linked recessive disorder transmitted through the maternal lineage, tracing back to Queen Victoria.

At the beginning of the 20th century, the absence of effective replacement therapy rendered hemophilia a life-threatening condition.

Recurrent hemarthroses, soft tissue hemorrhages, and potentially fatal bleeding episodes defined the clinical course.

Within this context, the emergence of Grigori Rasputin as a figure of perceived ‘healing’ influence has generated enduring controversy.

From a contemporary hematological perspective, there is no scientific evidence that Rasputin exerted any direct therapeutic effect on coagulation.

However, several plausible mechanisms may explain the observed clinical improvements during his involvement:

  • Discontinuation of harmful medical interventions, particularly aspirin, which was commonly administered at the time and is now known to impair platelet function
  • Psychological stabilization of the family environment, reducing stress-related exacerbation
  • Promotion of rest and immobilization, limiting further bleeding episodes
  • The natural, episodic course of hemophilia, where bleeding may cease spontaneously

Thus, Rasputin’s role can be interpreted not as that of a healer, but as an indirect modifier of clinical outcomes through behavioral and contextual influences.

Importantly, the Romanov case later contributed to the historical and genetic understanding of hemophilia.

Molecular analyses of the Romanov remains confirmed mutations in the Factor IX gene, validating the diagnosis of hemophilia B and reinforcing the well-established inheritance pattern.

A Contemporary Reflection: Hemophilia Is No Longer a Royal Disease

Today, hemophilia is no longer a mysterious or untreatable condition.

Advances in coagulation factor replacement, non-factor therapies such as emicizumab, and gene therapy have transformed patient outcomes.

Yet, a critical global inequity persists.

On this World Hemophilia Day, we must emphasize:

  • Access to early and accurate diagnosis is essential
  • Availability of safe and effective treatment must be universal
  • Hemophilia and bleeding disorders affect not only men, but also women and girls, who remain significantly underdiagnosed
  • Every patient with a bleeding disorder deserves dignity, visibility, and care

Hemophilia should not determine destiny – neither in imperial Russia nor in modern healthcare systems.

Call to Action

Equitable access to hemostasis care is not a privilege – it is a global responsibility.”

Heghine Khachatryan: From Imperial Tragedy to Modern Hemostasis - Lessons from the Romanov Case

Other posts featuring Heghine Khachatryan on Hemostasis Today.

bleeding disorders Factor IX Health Heghine Khachatryan Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today World Hemophilia Day
NewsFeed